Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Clinical trial NCT05169437 · TERMINATED

Trial details

NCT number: NCT05169437
Sponsor: Tempus AI
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Breast Tumor Colon Tumor, Malignant Lung Tumor Urologic Cancer Pancreatic Cancer Melanoma Metastatic Cancer Locally Advanced Solid Tumor Esophageal Cancer Endometrial Cancer Head and Neck Cancer

Start date: 2022-03-15
Primary completion: 2024-08-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.